BackgroundCheck.run
Search For

Stephen H Swenson DeceasedHawthorne, CA

Known as:
Steve H Swenson Kstephen Swenson Esq Swenson Steven Swenson Swenson Esq
Related to:
Kenneth L Swenson 62

Stephen Swenson Phones & Addresses

Hawthorne, CA   

Manhattan Beach, CA   

Redondo Beach, CA   

Chico, CA   

Get Report
Control this profile

Mentions for Stephen H Swenson

Career records & work history

Medicine Doctors

Stephen S. Swenson

Specialties:
Psychiatry, Addiction Medicine
Work:
Recovery Plus
713 Anderson Ave, Saint Cloud, MN 56303
320-2293760 (phone) 320-2293765 (fax)
Education:
Medical School
Mayo Medical School
Graduated: 1980
Conditions:
Acute Upper Respiratory Tract Infections, Alcohol Dependence, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Attention Deficit Disorder (ADD), Bipolar Disorder, Chronic Sinusitis, Depressive Disorders, Diabetes Mellitus (DM), Hypertension (HTN), Intervertebral Disc Degeneration, Otitis Media, Overweight and Obesity, Peripheral Nerve Disorders, Psoriasis, Schizophrenia, Substance Abuse and/or Dependency
Languages:
English
Description:
Dr. Swenson graduated from the Mayo Medical School in 1980. He works in Saint Cloud, MN and specializes in Psychiatry and Addiction Medicine. Dr. Swenson is affiliated with Saint Cloud Hospital.
Stephen Swenson Photo 1

Stephen S Swenson

Specialties:
General Practice
Addiction Medicine
Addiction Medicine
Addiction Medicine
Education:
Mayo Medical School (1980)

Stephen Swenson resumes & CV records

Resumes

Stephen Swenson Photo 35

Stephen Swenson

Stephen Swenson Photo 36

Stephen Swenson

Publications & IP owners

Us Patents

Method Of Expressing Proteins With Disulfide Bridges With Enhanced Yields And Activity

US Patent:
2011030, Dec 8, 2011
Filed:
Nov 12, 2009
Appl. No.:
13/127970
Inventors:
Radu O. Minea - Arcadia CA, US
Stephen D. Swenson - Arcadia CA, US
Assignee:
University of Southern California - Los Angeles CA
International Classification:
C12P 21/02
C12P 21/00
US Classification:
435 697
Abstract:
Provided herein are methods for expressing proteins with disulfide bridges such as Vicrostatin (VCN), a chimeric variant of native snake venom disintegrin Contortrostatin (CN). The methods include what is believed to be a more efficient natural selection process that results in generating increased amounts of correctly-folded active conformers of proteins with disulfide bridges. In an aspect, this is achieved by growing Origami B cells in a more optimal redox environment during the induction of heterologous recombinant protein production.

Bioadhesive Patch For Sutureless Closure Of Soft Tissue

US Patent:
2012014, Jun 7, 2012
Filed:
Feb 12, 2010
Appl. No.:
13/201433
Inventors:
Francis S. Markland - Manhattan Beach CA, US
Stephen D. Swenson - Arcadia CA, US
Radu O. Minea - Arcadia CA, US
International Classification:
A61K 38/02
C12N 5/0797
C12N 5/071
US Classification:
514 177, 514 208, 514 11, 435395
Abstract:
Provided herein are compositions and methods for treating soft tissue injuries using a patch having a polymer on its surface linked to polypeptides having a disintegrin domain. The polypeptides having a disintegrin domain can include contortrostatin, vicrostatin, and ADAM derived polypeptides. Compositions of the invention can be used for the treatment of injuries to soft tissues that include the eye, liver and brain.

Compositions And Methods For Inhibiting Viral Infection

US Patent:
2013017, Jul 11, 2013
Filed:
Nov 12, 2012
Appl. No.:
13/674827
Inventors:
University of Southern California - Los Angeles CA, US
Western University of Health Sciences - Pomona CA, US
Stephen Swenson - Glendale CA, US
Vaibhav Tiwari - Pomona CA, US
Assignee:
WESTERN UNIVERSITY OF HEALTH SCIENCES - Pomona CA
UNIVERSITY OF SOUTHERN CALIFORNIA - Los Angeles CA
International Classification:
A61K 38/17
A61K 45/06
A61K 38/44
C12Q 1/02
A61K 38/48
US Classification:
424 854, 435375, 514 37, 424 9467, 424 944, 514 42, 4242041, 435 5, 530350, 435219
Abstract:
Provided herein are compositions and methods for inhibiting viral infection of a host cell. The methods comprise contacting the the host cell with an effective amount of one or more polypeptides having a disintegrin domain. The polypeptide can be CN, VCN or modified ADAM-derived polypeptide (MAP), or a fusion protein comprising a CN, VCN or MAP.

Thrombolytic Agents With Antithrombotic Activity

US Patent:
5951981, Sep 14, 1999
Filed:
Dec 2, 1996
Appl. No.:
8/753781
Inventors:
Francis S. Markland - Manhattan Beach CA
Larry R. Bush - Exeter NH
Stephen Swenson - Arcadia CA
Eladio Flores Sanchez - Belo Horizonte-ma, BR
Assignee:
Diatide, Inc. - Londonderry NH
International Classification:
A61K 3854
A61K 3846
C12N 996
C12N 948
US Classification:
424 9467
Abstract:
This invention provides thrombolytic agents and methods for making and using thrombolytic agents. Specifically, the invention provides thrombolytic agents comprising a thrombolytic proteinase and a specific binding peptide that specifically binds at the site of blood clots and thrombi in vivo. The invention particularly provides chemically crosslinked conjugates of a thrombolytic proteinase and a plurality of specific binding peptide. Methods for producing such chemically crosslinked conjugates and methods for using such conjugates for eliminating thrombi in vivo to alleviate pathological conditions caused thereby are also provided. The preferred thrombolytic proteinase in the conjugate is fibrolase obtainable from Agkistrodon contortrix confortrix venom.

Size Enhanced Fibrinolytic Enzymes: Limitations Of Plasma Inactivation

US Patent:
6214594, Apr 10, 2001
Filed:
May 6, 1999
Appl. No.:
9/306150
Inventors:
Francis S. Markland - Manhattan Beach CA
Stephen D. Swenson - Arcadia CA
Assignee:
University of California - Los Angeles CA
International Classification:
C12N 1106
C12N 1110
C12N 1112
C12N 1108
C12N 996
C12N 948
US Classification:
435181
Abstract:
A size modified fibrinolytic enzyme, wherein the size of the enzyme is modified by covalent attachment of at least one large organic molecule to the enzyme.

Radiolabeled Disintegrins As Brachytherapy Agents

US Patent:
2018035, Dec 13, 2018
Filed:
Nov 11, 2016
Appl. No.:
15/775743
Inventors:
- Los Angeles CA, US
Francis S. Markland - Los Angeles CA, US
Radu O. Minea - Los Angeles CA, US
Stephen D. Swenson - Los Angeles CA, US
International Classification:
A61K 51/08
A61K 38/17
A61P 35/00
Abstract:
A method for suppressing or inhibiting the growth of a cancer cell or tumor cell that expresses one or more integrins on its cell surface in a subject in need thereof is disclosed, herein, the method comprising administering to the subject an effective amount of contortrostatin (CN) and/or vicrostatin (VCN) or an equivalent of each thereof and wherein the CN and/or VCN or the equivalent of each thereof is conjugated to a therapeutic radioisotope.

Compositions And Methods For Treating Ovarian Cancer Including Preventing The Recurrence Thereof

US Patent:
2016031, Nov 3, 2016
Filed:
Sep 25, 2014
Appl. No.:
15/080401
Inventors:
Stephen D. Swenson - Glendale CA, US
Radu O. Minea - Arcadia CA, US
Assignee:
University of Southern California - Los Angeles CA
International Classification:
A61K 38/16
A61K 45/06
Abstract:
A method of treating ovarian cancer (OC) includes administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising vicrostatin and/or a protein substantially similar to vicrostatin. The administration is preferably performed intraperitoneally. The methods may include concurrently or sequentially administering to the patient one or more additional treatments for ovarian cancer. A pharmaceutical composition used in connection with the methods of the present invention comprise vicrostatin loaded in a viscoelastic gel comprising polyethylene oxide (PEO) and carboxymethyl cellulose (CMC).

Amazon

Stephen Swenson Photo 38

The 30-Day Tax Lien Challenge: How To Invest In Tax Liens In Less Then 30 Days

Author:
Stephen Swenson, Shade Ferre
Publisher:
Tax Sale Solutions LLC
Binding:
Kindle Edition
Pages:
39
Hi this is Stephen and Shade the Tax Sale Cousins from Secretsoftaxlieninvesting.com. Are you interested in Buying Real Estate for 10% to 20% of the Properties Market Value? Or what about Earning Interest Rates Returns of 10%, 15% or even 18% with Tax Lien Certificates? The purpose of the 30 Day Cha...
Stephen Swenson Photo 39

The Insiders Tax Lien Investor Secrets - Book 1: A Revealing Look Into The World Of Tax Lien And Deed Investing

Author:
Stephen Swenson, Shade Ferre
Publisher:
PropertyTaxList.com
Binding:
Kindle Edition
Pages:
58
Tax Sale Investing E-Course "Tax Lien Investor Secrets" Volume 1: A revealing look into the world of tax lien and deed investing.Hi this is Stephen and Shade, the Tax Sale Cousins from PropertyTaxList.com. We have provided Tax Sale Training for some of the largest seminar companies in the United Sta...
Stephen Swenson Photo 40

Tumor Angiogenesis

Publisher:
Wiley-Blackwell
Binding:
Hardcover
Pages:
351
ISBN #:
3527320911
EAN Code:
9783527320912
Covering one of the most important research topics in cancer biology, this is an ideal ready reference for oncologists, cell biologists, pharmaceutists, pathologists, molecular biologists, internists, and researchers working in the pharmaceutical industry. Following an introduction that provides an ...
Stephen Swenson Photo 41

Playbill, The Broadhurst Theatre: 110 In The Shade (Vol. 1, April 1964, No. 4) (Robert Horton, Inga Swenson, Stephen Douglass)

Author:
Sandy Lesberg, Malcolm Muggeridge, Sylvia Leonard, Louis Marder, Bernice Peck
Publisher:
Playbill Incorporated
Binding:
Pamphlet
Pages:
56
Playbill, The Broadhurst Theatre: 110 in the Shade (Vol. 1, April 1964, No. 4) (Robert Horton, Inga Swenson, Stephen Douglass), edited by Leo Lerman. 1964 paperback booklet/pamphlet/program published by Playbill Incorporated. Features advertisements for Buick Riviera, Oldsmobile Vista-Cruiser, Chrys...

Possible Relatives

Cynthia M Swenson  David L Swenson  Dawn M Swenson  Denise H Swenson  Danielle N Swenson  Darlene M Swenson  Elaine F Swenson  Stephen H Last  Stephen V Johnson  Stephen Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.